[Analysis of vesicoureteral reflux (VUR) course in children].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 18634285)

Published in Pol Merkur Lekarski on March 01, 2008

Authors

Katarzyna Taranta-Janusz1, Anna Wasilewska, Walentyna Zoch-Zwierz, Agata Korzeniecka-Kozerska

Author Affiliations

1: Akademia Medyczna w Białymstoku, I Klinika Chorób Dzieci.

Articles by these authors

Hematological parameters in adolescents with hyperuricemia. Indian Pediatr (2014) 2.00

Assessment of lithogenic risk in children based on a morning spot urine sample. J Urol (2010) 1.45

Polish 2010 growth references for school-aged children and adolescents. Eur J Pediatr (2010) 1.40

KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatr Nephrol (2011) 1.23

Genetic screening in adolescents with steroid-resistant nephrotic syndrome. Kidney Int (2013) 1.21

Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity? Pediatr Nephrol (2010) 1.11

Perception of health-related quality of life in children with chronic kidney disease by the patients and their caregivers: multicentre national study results. Qual Life Res (2013) 0.94

A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index. Pediatr Nephrol (2008) 0.92

Hypertension in dialysed children: the prevalence and therapeutic approach in Poland--a nationwide survey. Nephrol Dial Transplant (2005) 0.91

MDR-1 gene polymorphisms and clinical course of steroid-responsive nephrotic syndrome in children. Pediatr Nephrol (2006) 0.90

Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children. Pediatr Nephrol (2007) 0.89

Perivascular epithelioid tumor (PEComa) of the falciform/ broad ligament. Pol J Pathol (2008) 0.87

Effect of cyclosporin A on proteinuria in the course of glomerulopathy associated with WT1 mutations. Eur J Pediatr (2010) 0.86

Does obesity or hyperuricemia influence lithogenic risk profile in children with urolithiasis? Pediatr Nephrol (2014) 0.86

Urinary cytokine profiles in unilateral congenital hydronephrosis. Pediatr Nephrol (2012) 0.84

Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome. Pediatr Nephrol (2014) 0.83

Response to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndrome. Pediatr Nephrol (2008) 0.81

Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children. Pediatr Nephrol (2010) 0.81

Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria. Scand J Urol Nephrol (2010) 0.81

Urinary angiotensinogen as a marker of intrarenal angiotensin II activity in adolescents with primary hypertension. Pediatr Nephrol (2013) 0.81

Evaluation of bladder instability in children with recurrent urinary tract infections. Med Sci Monit (2002) 0.81

Assessment of serum cystatin C in children with congenital solitary kidney. Pediatr Nephrol (2006) 0.81

Urinary angiotensinogen as a novel marker of obstructive nephropathy in children. Acta Paediatr (2013) 0.80

Correspondence between Ca²⁺ and calciuria, citrate level and pH of urine in pediatric urolithiasis. Pediatr Nephrol (2013) 0.80

Expression of glucocorticoid receptors in mononuclear cells in nephrotic syndrome. Pediatr Nephrol (2003) 0.80

A potential pathogenic role of oxalate in autism. Eur J Paediatr Neurol (2011) 0.80

Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy. Pediatr Nephrol (2014) 0.79

Expression of P-glycoprotein in lymphocytes from children with nephrotic syndrome, depending on their steroid response. Pediatr Nephrol (2006) 0.79

Epidemiological study of acute poisoning in children: a 5-year retrospective study in the Paediatric University Hospital in Białystok, Poland. Emerg Med J (2012) 0.79

Osteopontin and symmetric dimethylarginine plasma levels in solitary functioning kidney in children. Acta Paediatr (2012) 0.79

Functional bladder capacity and urine osmolality in children with primary monosymptomatic nocturnal enuresis. Scand J Urol Nephrol (2005) 0.79

Paediatric normative data for urine NGAL/creatinine ratio. Acta Paediatr (2013) 0.78

Psychosocial aspects of children and families of children treated with automated peritoneal dialysis. Pediatr Nephrol (2013) 0.78

Reference values of plasma oxalate in children and adolescents. Pediatr Nephrol (2008) 0.78

Glucocorticoid receptor and vascular endothelial growth factor in nephrotic syndrome. Acta Paediatr (2006) 0.78

A need to establish normative data for plasma oxalates. Am J Kidney Dis (2008) 0.78

Is plasma symmetric dimethylarginine a suitable marker of renal function in children and adolescents? Scand J Urol Nephrol (2011) 0.78

Mutational analysis in podocin-associated hereditary nephrotic syndrome in Polish patients: founder effect in the Kashubian population. J Appl Genet (2013) 0.78

Serum 25-hydroxyvitamin D, osteocalcin, and parathormone status in children with meningomyelocele. Neuropediatrics (2012) 0.77

[Serum and urinary homocysteine in children with steroid-dependent nephrotic syndrome]. Pol Merkur Lekarski (2011) 0.77

[WT1 mutation as a cause of progressive nephropathy in Frasier syndrome--case report]. Pol Merkur Lekarski (2009) 0.77

Urine NGAL and KIM-1 in children and adolescents with hyperuricemia. Pediatr Nephrol (2013) 0.77

Serum copeptin levels in adolescents with primary hypertension. Pediatr Nephrol (2013) 0.77

Urinary nerve growth factor level in children with neurogenic bladder due to myelomeningocele. Scand J Urol (2013) 0.77

[Chronic peritoneal dialysis in infants--preliminary results of the multicenter survey]. Przegl Lek (2006) 0.76

Urine fibroblast growth factor 23 levels in hypertensive children and adolescents. Croat Med J (2015) 0.76

Urinary transforming growth factor beta1 in children and adolescents with congenital solitary kidney. Pediatr Nephrol (2008) 0.76

Laminin and transforming growth factor beta-1 in children with vesicoureteric reflux. Pediatr Nephrol (2008) 0.76

Is symmetric dimethylarginine a sensitive biomarker of subclinical kidney injury in children born with low birth weight? Biomarkers (2014) 0.76

[FGF23 and Klotho protein--the role in the pathogenesis of hypertension]. Wiad Lek (2015) 0.76

Serum and urine leptin concentration in children with nephrotic syndrome. Pediatr Nephrol (2005) 0.75

High-sensitivity C-reactive protein (hs-CRP) level in children with nephrotic syndrome. Pediatr Nephrol (2006) 0.75

Expression of glucocorticoid receptors in nephrotic children depending on total prednisone dose. J Pediatr Endocrinol Metab (2005) 0.75

Anxiety in children and adolescents with chronic kidney disease--multicenter national study results. Kidney Blood Press Res (2013) 0.75

Normal values for urine renalase excretion in children. Pediatr Nephrol (2014) 0.75

Evaluation of Serum Uric Acid: Authors' Reply. Indian Pediatr (2015) 0.75

Asymmetric and symmetric dimethylarginine in adolescents with hyperuricemia. Dis Markers (2013) 0.75

The effects of breastfeeding on serum asymmetric dimethylarginine levels and body composition in children. Breastfeed Med (2014) 0.75

Is the serum level of salusin-β associated with hypertension and atherosclerosis in the pediatric population? Pediatr Nephrol (2014) 0.75

New tubular injury markers in children with a solitary functioning kidney. Pediatr Nephrol (2014) 0.75

Urinary citrate excretion in healthy children depends on age and gender. Pediatr Nephrol (2014) 0.75

Urinary MMP-9/NGAL ratio as a potential marker of FSGS in nephrotic children. Dis Markers (2013) 0.75

Round Table Discussion. Ann Nutr Metab (2016) 0.75

[Evaluation of inflammatory and renal injury markers in youngest children with pyelonephritis]. Pol Merkur Lekarski (2008) 0.75

[Urinary laminin and fibronectin level in children with nephritic syndrome]. Pol Merkur Lekarski (2009) 0.75

[Assessment of fructose-1,6-biphosphatase in urine of children with acute pyelonephritis]. Pol Merkur Lekarski (2004) 0.75

[Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in the urine of children with pyelonephritis]. Pol Merkur Lekarski (2009) 0.75

High-sensitivity C-reactive protein and mean platelet volume in paediatric hypertension. Pediatr Nephrol (2010) 0.75

[The evaluation of urinary tract dysfunction in children with monosymptomatic primary nocturnal enuresis]. Pol Merkur Lekarski (2008) 0.75

[Carriage of Streptococcus pneumoniae in nasopharynx in children with nephrotic syndrome aged 2-5 years in Poland]. Pol Merkur Lekarski (2008) 0.75

[Reference values of 24-hour ambulatory blood pressure in healthy children by height]. Pol Merkur Lekarski (2004) 0.75

[Serum cystatin C concentration in children with urinary stones]. Pol Merkur Lekarski (2006) 0.75

Primary soft tissue giant cell tumour of the neck. Cytological and histological characteristics of the tumour and differential diagnosis. Pol J Pathol (2009) 0.75

[Role of matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) in nephrology]. Przegl Lek (2009) 0.75

Urodynamic Findings and Renal Function in Children with Neurogenic Bladder after Myelomeningocele. Urol Int (2015) 0.75

[Assessment of transforming growth factor-beta1 in serum of children with idiopathic nephrotic syndrome depending on the way of treatment]. Pol Merkur Lekarski (2003) 0.75

Serum and urine fibronectin levels in children with vesicoureteral reflux. Pediatr Nephrol (2007) 0.75

Spontaneous urinary calcium oxalate crystallization in hypercalciuric children. Pediatr Nephrol (2009) 0.75

[Vasculitis of cerebral vessels, probable cause of neurological complications in a child with Schonlein-Henoch purpura]. Pol Merkur Lekarski (2002) 0.75

[Differences in dietary habits and food preferences of adults depending on the age]. Rocz Panstw Zakl Hig (2012) 0.75

[Serum and urinary concentration of selected metalloproteinases and their tissue inhibitors in children with vesicoureteral reflux]. Pol Merkur Lekarski (2010) 0.75

[Urinary TGF-beta1 excretion in children with renal cysts]. Przegl Lek (2006) 0.75